◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items

BIO GREEN MED SOLUTION, INC.

CIK: 1130166 SIC: 2834
-
Revenue
$-5.44M
Net Income
-
Gross Margin
-
Op. Margin
$-13.64M
Free Cash Flow
Financial Statements Annual (10-K)
Showing 5 of 13 annual reports available (2011 - 2024)
Breakdown TTM
(Sep 30, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2021
(Dec 31, 2021)
FY 2020
(Dec 31, 2020)
FY 2019
(Dec 31, 2019)
+ Total Revenue - $43.00K $420.00K - - -
Revenue Growth % nan% -89.8% nan% nan% nan% nan%
Operating Expenses $9.25M $12.05M $25.87M $22.94M $10.64M $9.68M
Research & Development $1.77M $6.66M $19.16M $15.48M $4.76M $4.66M
Selling General & Admin - $5.39M $6.72M $7.46M $5.88M $5.02M
+ Operating Income $-9.17M $-12.00M $-25.45M $-22.94M $-10.64M $-9.68M
Operating Margin % nan% -27916.3% -6060.2% nan% nan% nan%
Interest Income - $12.00K $266.00K $16.00K $42.00K $224.00K
Other Income/Expense $21.00K $52.00K $50.00K $204.00K $955.00K $556.00K
Income Before Tax $-4.24M $-11.99M $-25.55M $-22.73M $-9.68M $-9.13M
Income Tax Expense - $-782.00K $-3.00M $-3.85M $-1.24M $-1.30M
+ Net Income $-5.44M $-11.21M $-22.55M $-18.89M $-8.45M $-7.83M
Net Margin % nan% -26074.4% -5370.2% nan% nan% nan%
Basic EPS 485.63 -2.09 -26.75 -2.14 -3.42 nan
Diluted EPS 485.63 -2.09 -26.75 -2.14 -3.42 nan
Basic Shares Outstanding 1.9M - - 8.9M 3.6M -
Diluted Shares Outstanding 1.9M - - 8.9M 3.6M -
Breakdown FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2021
(Dec 31, 2021)
FY 2020
(Dec 31, 2020)
FY 2019
(Dec 31, 2019)
Cash & Cash Equivalents $3.14M $3.38M $36.56M $33.41M $11.88M
Other Current Assets $537.00K $4.07M $4.38M $2.06M $2.13M
Total Current Assets $3.67M $7.44M $40.94M $35.47M $14.02M
Property Plant & Equipment $3.00K $9.00K $64.00K $106.00K $27.00K
Total Assets $4.09M $8.80M $42.59M $36.80M $15.31M
Accounts Payable $4.60M $3.54M $2.12M $514.00K $890.00K
Accrued Liabilities $1.67M $4.62M $3.18M $1.97M $1.53M
Total Current Liabilities $6.27M $8.16M $5.29M $2.49M $2.42M
Total Liabilities $6.27M $8.20M $5.32M $3.54M $3.61M
Common Stock $9.00K $1.00K $10.00K $6.00K $17.00K
Retained Earnings $-439.49M $-428.28M $-384.96M $-366.07M $-357.63M
Total Stockholders Equity $-2.17M $607.00K $37.26M $33.26M $11.70M
Total Liabilities & Equity $4.09M $8.80M $42.59M $36.80M $15.31M
Breakdown TTM
(Sep 30, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2021
(Dec 31, 2021)
FY 2020
(Dec 31, 2020)
FY 2019
(Dec 31, 2019)
Net Income $-5.44M $-11.21M $-22.55M $-18.89M $-8.45M $-7.83M
Stock-based Compensation $5.11M $592.00K $1.47M $1.16M $430.00K $466.00K
Operating Cash Flow $-13.64M $-7.99M $-16.11M $-18.54M $-7.93M $-9.45M
Capital Expenditure - - $6.00K $27.00K $96.00K $10.00K
Investing Cash Flow - - $-6.00K $-27.00K $-96.00K $28.00K
Stock Issued - - - - $29.70M $4.05M
Financing Cash Flow $16.31M $7.82M $848.00K $21.74M $29.50M $3.85M
Net Change in Cash $2.31M $-241.00K $-14.97M $3.15M $21.52M $-5.62M
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Total Revenue $81.00K - $81.00K -
Cost of Revenue $64.00K - $64.00K -
Operating Expenses $1.07M - $7.43M -
Research & Development $5.00K - $895.00K -
Operating Income $-992.00K - $-7.34M -
Interest Expense - - $6.00K -
Other Income/Expense $9.00K - $21.00K -
Income Before Tax $-988.00K - $-2.38M -
Income Tax Expense - - $2.00K -
Net Income $-988.00K $-3.26M $-2.39M -
Basic EPS -1.31 - -2.86 -
Diluted EPS -1.31 - -2.86 -
Basic Shares Outstanding $1.91M - $1.37M -
Diluted Shares Outstanding $1.91M - $1.37M -
Condensed Consolidated Balance Sheets
Description Sep 30, 2025 Dec 31, 2024
Cash & Cash Equivalents $3.84M $3.14M
Accounts Receivable $725.00K -
Inventory $1.37M -
Other Current Assets $513.00K $537.00K
Total Current Assets $6.44M $3.67M
Property Plant & Equipment $129.00K $3.00K
Goodwill $1.57M -
Total Assets $8.16M $4.09M
Accounts Payable $468.00K $4.60M
Accrued Liabilities $534.00K $1.67M
Total Current Liabilities $1.00M $6.27M
Total Liabilities $1.06M $6.27M
Common Stock $3.00K -
Retained Earnings $-444.26M $-439.49M
Total Stockholders Equity $7.10M $-2.17M
Total Liabilities & Equity $8.16M $4.09M
Condensed Consolidated Statements of Cash Flows
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Net Income $-988.00K $-3.26M $-2.39M -
Stock-based Compensation - - $1.68M -
Change in Receivables - - $725.00K -
Change in Inventory - - $1.37M -
Operating Cash Flow - - $-4.74M -
Investing Cash Flow - - - -
Financing Cash Flow - - $5.52M -
Net Change in Cash - - $701.00K -

All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-K filings.

Annual data represents full fiscal year results. FY = Fiscal Year ending.

NEWS
Loading news...
TRENDING
Loading...